Vol.
40
No.
10
March 07, 2014Mar 07, 2014
Free


Cover Story
NIH has launched a systematic examination of its intramural program, which accounts for 11.1 percent of its $30 billion budget.
In Brief
Trending Stories
- How George Tidmarsh crossed the FDA-industry Rubicon
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval - Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
- City of Hope’s leadership in lung cancer: Precision, innovation, and a vision for cure
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA
- Mary Pazdur, 63, Dies of Cancer; What Her Husband Has Learned











